Glucocorticoids Reprogram Beta Cell Signaling to Preserve Insulin Secretion

NHF Fine, CL Doig, YS Elhassan, NC Vierra, P Marchetti, Marco Bugliani, R Nano, L Piemonti, GA Rutter, DA Jacobson, GG Lavery, DJ Hodson

Research output: Contribution to journalArticle

Abstract

Excessive glucocorticoid exposure has been shown to be deleterious for pancreatic beta cell function and insulin release. However, glucocorticoids at physiological levels are essential for many homeostatic processes, including glycemic control. Here, we show that corticosterone and cortisol and their less active precursors, 11-dehydrocorticosterone (11-DHC) and cortisone, suppress voltage-dependent Ca2+ channel function and Ca2+ fluxes in rodent as well as human beta cells. However, insulin secretion, maximal ATP/ADP responses to glucose and beta cell identity were all unaffected. Further examination revealed the upregulation of parallel amplifying cAMP signals, and an increase in the number of membrane-docked insulin secretory granules. Effects of 11-DHC could be prevented by lipotoxicity and were associated with paracrine regulation of glucocorticoid activity, since global deletion of 11β-hydroxysteroid dehydrogenase type 1 normalized Ca2+ and cAMP responses. Thus, we have identified an enzymatically-amplified feedback loop whereby glucocorticoids boost cAMP to maintain insulin secretion in the face of perturbed ionic signals. Failure of this protective mechanism may contribute to diabetes in states of glucocorticoid excess such as Cushing's syndrome, which are associated with frank dyslipidemia. © 2017 by the American Diabetes Association.
Original languageEnglish
Pages (from-to)278-290
Number of pages13
JournalDiabetes
Volume67
Issue number2
DOIs
Publication statusPublished - 2018

Fingerprint

Glucocorticoids
Insulin
11-beta-Hydroxysteroid Dehydrogenases
Cushing Syndrome
Cortisone
Secretory Vesicles
Insulin-Secreting Cells
Dyslipidemias
Corticosterone
Adenosine Diphosphate
Hydrocortisone
Rodentia
Up-Regulation
Adenosine Triphosphate
Glucose
Membranes
11-dehydrocorticosterone

Cite this

Fine, NHF., Doig, CL., Elhassan, YS., Vierra, NC., Marchetti, P., Bugliani, M., ... Hodson, DJ. (2018). Glucocorticoids Reprogram Beta Cell Signaling to Preserve Insulin Secretion. Diabetes, 67(2), 278-290. https://doi.org/10.2337/db16-1356

Glucocorticoids Reprogram Beta Cell Signaling to Preserve Insulin Secretion. / Fine, NHF; Doig, CL; Elhassan, YS; Vierra, NC; Marchetti, P; Bugliani, Marco; Nano, R; Piemonti, L; Rutter, GA; Jacobson, DA; Lavery, GG; Hodson, DJ.

In: Diabetes, Vol. 67, No. 2, 2018, p. 278-290.

Research output: Contribution to journalArticle

Fine, NHF, Doig, CL, Elhassan, YS, Vierra, NC, Marchetti, P, Bugliani, M, Nano, R, Piemonti, L, Rutter, GA, Jacobson, DA, Lavery, GG & Hodson, DJ 2018, 'Glucocorticoids Reprogram Beta Cell Signaling to Preserve Insulin Secretion', Diabetes, vol. 67, no. 2, pp. 278-290. https://doi.org/10.2337/db16-1356
Fine NHF, Doig CL, Elhassan YS, Vierra NC, Marchetti P, Bugliani M et al. Glucocorticoids Reprogram Beta Cell Signaling to Preserve Insulin Secretion. Diabetes. 2018;67(2):278-290. https://doi.org/10.2337/db16-1356
Fine, NHF ; Doig, CL ; Elhassan, YS ; Vierra, NC ; Marchetti, P ; Bugliani, Marco ; Nano, R ; Piemonti, L ; Rutter, GA ; Jacobson, DA ; Lavery, GG ; Hodson, DJ. / Glucocorticoids Reprogram Beta Cell Signaling to Preserve Insulin Secretion. In: Diabetes. 2018 ; Vol. 67, No. 2. pp. 278-290.
@article{029d7c95f4064049b233c45b76ff2485,
title = "Glucocorticoids Reprogram Beta Cell Signaling to Preserve Insulin Secretion",
abstract = "Excessive glucocorticoid exposure has been shown to be deleterious for pancreatic beta cell function and insulin release. However, glucocorticoids at physiological levels are essential for many homeostatic processes, including glycemic control. Here, we show that corticosterone and cortisol and their less active precursors, 11-dehydrocorticosterone (11-DHC) and cortisone, suppress voltage-dependent Ca2+ channel function and Ca2+ fluxes in rodent as well as human beta cells. However, insulin secretion, maximal ATP/ADP responses to glucose and beta cell identity were all unaffected. Further examination revealed the upregulation of parallel amplifying cAMP signals, and an increase in the number of membrane-docked insulin secretory granules. Effects of 11-DHC could be prevented by lipotoxicity and were associated with paracrine regulation of glucocorticoid activity, since global deletion of 11β-hydroxysteroid dehydrogenase type 1 normalized Ca2+ and cAMP responses. Thus, we have identified an enzymatically-amplified feedback loop whereby glucocorticoids boost cAMP to maintain insulin secretion in the face of perturbed ionic signals. Failure of this protective mechanism may contribute to diabetes in states of glucocorticoid excess such as Cushing's syndrome, which are associated with frank dyslipidemia. {\circledC} 2017 by the American Diabetes Association.",
author = "NHF Fine and CL Doig and YS Elhassan and NC Vierra and P Marchetti and Marco Bugliani and R Nano and L Piemonti and GA Rutter and DA Jacobson and GG Lavery and DJ Hodson",
year = "2018",
doi = "10.2337/db16-1356",
language = "English",
volume = "67",
pages = "278--290",
journal = "Diabetes",
issn = "0012-1797",
publisher = "American Diabetes Association Inc.",
number = "2",

}

TY - JOUR

T1 - Glucocorticoids Reprogram Beta Cell Signaling to Preserve Insulin Secretion

AU - Fine, NHF

AU - Doig, CL

AU - Elhassan, YS

AU - Vierra, NC

AU - Marchetti, P

AU - Bugliani, Marco

AU - Nano, R

AU - Piemonti, L

AU - Rutter, GA

AU - Jacobson, DA

AU - Lavery, GG

AU - Hodson, DJ

PY - 2018

Y1 - 2018

N2 - Excessive glucocorticoid exposure has been shown to be deleterious for pancreatic beta cell function and insulin release. However, glucocorticoids at physiological levels are essential for many homeostatic processes, including glycemic control. Here, we show that corticosterone and cortisol and their less active precursors, 11-dehydrocorticosterone (11-DHC) and cortisone, suppress voltage-dependent Ca2+ channel function and Ca2+ fluxes in rodent as well as human beta cells. However, insulin secretion, maximal ATP/ADP responses to glucose and beta cell identity were all unaffected. Further examination revealed the upregulation of parallel amplifying cAMP signals, and an increase in the number of membrane-docked insulin secretory granules. Effects of 11-DHC could be prevented by lipotoxicity and were associated with paracrine regulation of glucocorticoid activity, since global deletion of 11β-hydroxysteroid dehydrogenase type 1 normalized Ca2+ and cAMP responses. Thus, we have identified an enzymatically-amplified feedback loop whereby glucocorticoids boost cAMP to maintain insulin secretion in the face of perturbed ionic signals. Failure of this protective mechanism may contribute to diabetes in states of glucocorticoid excess such as Cushing's syndrome, which are associated with frank dyslipidemia. © 2017 by the American Diabetes Association.

AB - Excessive glucocorticoid exposure has been shown to be deleterious for pancreatic beta cell function and insulin release. However, glucocorticoids at physiological levels are essential for many homeostatic processes, including glycemic control. Here, we show that corticosterone and cortisol and their less active precursors, 11-dehydrocorticosterone (11-DHC) and cortisone, suppress voltage-dependent Ca2+ channel function and Ca2+ fluxes in rodent as well as human beta cells. However, insulin secretion, maximal ATP/ADP responses to glucose and beta cell identity were all unaffected. Further examination revealed the upregulation of parallel amplifying cAMP signals, and an increase in the number of membrane-docked insulin secretory granules. Effects of 11-DHC could be prevented by lipotoxicity and were associated with paracrine regulation of glucocorticoid activity, since global deletion of 11β-hydroxysteroid dehydrogenase type 1 normalized Ca2+ and cAMP responses. Thus, we have identified an enzymatically-amplified feedback loop whereby glucocorticoids boost cAMP to maintain insulin secretion in the face of perturbed ionic signals. Failure of this protective mechanism may contribute to diabetes in states of glucocorticoid excess such as Cushing's syndrome, which are associated with frank dyslipidemia. © 2017 by the American Diabetes Association.

U2 - 10.2337/db16-1356

DO - 10.2337/db16-1356

M3 - Article

VL - 67

SP - 278

EP - 290

JO - Diabetes

JF - Diabetes

SN - 0012-1797

IS - 2

ER -